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N-myc downstream regulated gene-1 participates in carcinogenesis, angiogenesis, metastases, and anticancer drug resistance. In
the present study, we analyzed the expression pattern of N-myc downstream regulated gene-1 following treatment of human
colonic cancer cell lines; HCT-116 (well diﬀerentiated with wild-type p53 gene) and Colo-320 (poorly diﬀerentiated with mutant
p53 gene), with 3,3 -diindolylmethane, a well-established proapoptotic agent product derived from indole-3-carbinol. Treatment
of Colo-320 and HCT-116 with 3,3 -diindolylmethane disclosed inhibition of cell viability in a dose-dependent manner, mediated
through apoptosis induction. The increased expression of N-myc downstream regulated gene-1 was detected only in poorly
diﬀerentiated colon cancer cells, Colo-320 cell line. Our results suggest that N-myc downstream regulated gene-1 expression is
enhanced by 3,3 -diindolylmethane in poorly diﬀerentiated cells and followed by induction of apoptosis. 3,3 -diindolylmethane
induced apoptosis may represent a new regulator of N-myc downstream regulated gene-1 in poorly diﬀerentiated colonic cancer
cells.
1.Introduction
N-myc downstream regulated 1 gene (NDRG1) is a 43-
kDa protein located mainly in the cytoplasm but occa-
sionally translocates into the nucleus in a p53-dependent
manner [1]. This protein interacts with many cell elements
and consequently participates in various processes in the
cells, such as diﬀerentiation, response to stress conditions,
involvement in carcinogenesis, angiogenesis, and metastasis.
NDRG1 is induced, among others, by stress conditions,
inhibition of DNA methylation, and histone deacetylation
[2–7]. Furthermore, NDRG1 is necessary for caspase-3
activation and is required for p53-dependent apoptosis in
a cell type-speciﬁc manner [8]. Nevertheless, the precise
function of NDRG1 and its regulation in cancer cells is far
from being clear.
In colon cancer, NDRG1 protein levels appear to be
decreased with the progression from normal colonic epithe-
lium to carcinoma [9, 10]. Moreover, NDRG1 expression is
associatedwithamoreaggressivetumorphenotypeandpoor
outcome in colorectal cancer [11].
NDRG1 mediates apoptosis in several tissues [8, 12,
13]. However, the regulation of NDRG1 during apoptosis
state in cancer cells in general, and in colon cancer in
particular, was not explored previously. The purpose of
the current study was to investigate the NDRG1 expression
pattern in human colon cancer cell lines which vary in
their diﬀerentiation level and in their p53 status. For
apoptosis induction, we used 3,3 -diindolylmethane (DIM),
a well-established proapoptotic agent product derived from
indole-3-carbinol (I3C). In a low environmental pH, I3C
is converted into polymeric products, among which 3,3 -
diindolylmethane (DIM) is the main one. Studies showed
that DIM induced cell-cycle arrest in human prostate cancer
through, the upregulation of cycline-dependent kinases [14]
and apoptosis via mitochondrial pathway [15–21].2 Journal of Biomedicine and Biotechnology
2.MaterialsandMethods
2.1. Cell Culture and Treatment. Two human colon cancer
cell lines HCT-116 (well diﬀerentiated, p53 wild type) and
Colo-320 (poorly diﬀerentiated, p53 mutant) were grown in
a medium 10% fetal calf serum and 100U/mL penicillin-
streptomycin in the presence of DIM (10–100μM). Cell
viability (XTT) [22], cytotoxicity, and leakage of lactate
dehydrogenase [23, 24] were tested 24, 48, and 72 hours after
treatment.
DAPI staining for visualization of chromatin condensa-
tion [25] were conducted after treatment with 60μMD I M
for 72hr [26].
2.2. RNA Isolation and Real-Time PCR. RNA from colon
cancer cells was isolated using Tri-reagent (Tal-Ron).
Total RNA (3 μg) was reverse-transcribed to cDNA.
1197bp product of NDRG1 was ampliﬁed by real-time
PCR (ABI Prism 7900) using probe and the following
primers: 5 -AGGGACATGTCTCGGGAGATGCAGGAT-3 
and 5 -GGCCGCCTAGCAGGAGACCTCCATGG-3 .A s
a control gene, we ampliﬁed β-actin (838bp) with 5 -
ATCTGGCACCACACCTTCTACAATGAGCTGCG-3  and
5 -CGTCATACTCCT GCTTGCTGATCCACATCTGC-3 .
Alkaline phosphatase activity assay [27]w a sc o n d u c t e d4
and 8h after treatment with 60μMD I M .
2.3. Statistical Analysis. Data analyses were carried out using
SPSS version 17. Experiments were repeated three times,
each performed in triplicate, and the data are presented as
means ± SD (Standard Deviation). Statistical analysis of
the diﬀerences between controls and treated groups were
performed using Student’s t-test. P<0.05 was considered
signiﬁcant.
3. Results
3.1. DIM Reduced Cell Viability by Apoptosis Induction. We
observed that the two colon cancer cells treated with DIM
(10–80μM) for 72hr had a signiﬁcant inhibitory eﬀect (P<
0.001) in a dose-dependent manner (Figure 1). The IC50
values were 52μMf o rH C T - 1 1 6a n d5 6 μM for Colo-320.
Furthermore, no toxic eﬀects were manifested for these
concentrations, as it was determined with LDH enzyme
activity (Data not shown).
Following the reduced viability, apoptosis was tested
in cells treated with DIM (60μM) for 72hr (Figure 2(a)).
Both cell lines showed DNA fragmentation, a main feature
of apoptosis occurrence. In addition, cell treatment with
60μM DIM for 48h followed by DAPI staining (Figure 2(b))
showed apoptotic cells that exhibited typical apoptotic mor-
phology, condensation, and fragmentation of the nucleus, in
comparison to untreated cells.
3.2. Alteration in NDRG1 Expression in Colo 320. Basal
expression of NDRG1 prior treatment showed low levels of
mRNA and no expression of protein in Colo 320 cell lines;
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Figure 1: Eﬀect of DIM on cell viability. Exponentially growing
cells were incubated in the presence of 10 to 100μMo fD I Mf o r7 2
hours, and the viable cells were detected by XTT assay. The results
are presented as percentage of control and expressed as means ± SD
of three independent experiments.
alternatively, high levels of both mRNA and protein were
detected in HCT-116 cell line (Data not shown).
Exposure of the Colo 320 to DIM for 24–72hr resulted
in a signiﬁcant increase (9-fold for 24h, 10-fold for 48h, and
15-fold for 72h following treatment) of the NDRG1 mRNA
levels (Figure 3). However, exposure of HCT-116 to DIM
resulted in uninﬂuenced expression of the NDRG1 mRNA
compared to control cells.
3.3. Eﬀect of DIM and NDRG1 Expression on Cell Diﬀerenti-
ation. Alkaline phosphatase activity, a molecular marker of
colon epithelial cells diﬀerentiation was used to determine
whether the increase in NDRG1 expression is related to
diﬀerentiation alteration in the cells. The results revealed
that treated cells had a nonsigniﬁcant increase of alkaline
phosphatase activity in Colo 320 cells and had no eﬀect in
HCT-116 cells (Figure 4).
4. Discussion
In the present study, we examined NDRG1 expression in
human colon cancer cells during apoptosis induced upon
DIM application. First, we showed that indol derivative
found in crucifers (DIM) induced apoptosis in both human
colon cancer cells HCT-116 and Colo 320. We have previ-
ously shown that DIM has a suppressive eﬀect on the growth
of breast cancer and prostate cell lines [15, 16, 20]. The
IC50 values for DIM on growth inhibition of colon cancer
cells (50–60μM) were similar to those found for prostate
and breast cancer cells (20–40μM and 17–30μM, resp.)
[15, 28]. DIM aﬀected the viability of the cancer cell in a
time- and dose-dependent manner irrespective of their p53
phenotype. The eﬀect was mediated by apoptosis as shown
morphologically and by DNA fragmentation. Thus, colonicJournal of Biomedicine and Biotechnology 3
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Figure 2: Apoptosis formation by DIM in Colo 320 and HGT116 cell lines. Cells were treated with DIM 60μM for 72 hours. DNA was
extracted and separated on a 1.5% Agarose gel. The data shown were repeated three times (a). Morphologic changes, denoting apoptotic
cells were shown by cell morphological changes. Cells were incubated in the presence of 60μM DIM for 48 hours and stained with DAPI.
Morphologic changes are shown by arrows (b). The data shown were repeated three times.
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Figure 3: Expression of NDRG1. Cells treated with 60μMD I Mf o r
24, 48 and 72h. The levels of mRNA were examined by real-time
PCR and are represented as RQ (relative quantiﬁcation) = 2−ddCt.
∗P value <0.01, ∗∗P value <0.001.
cell lines can be added to an increasing list of other organs’
cell lines, namely, prostate and breast [16, 21, 29] that are
aﬀected by environmental factors which induce apoptosis.
The basal expression of NDRG1 reported here, high
levels in well-diﬀerentiated cells (HCT-116) and low levels
in poorly diﬀerentiated cells (Colo-320), was reported in
colon [30], gastric cancer specimens [31], and in esophageal
squamous cell carcinoma [32].
QuantizationofNDRG1expressionshowedthatNDRG1
mRNA is increased 9–15-fold (P<0.001) during treatment
of the Colo-320 cells with DIM for 24–72hr compared
to control cells, indicating NDRG1 upregulation during
apoptosis induced by DIM.
Up to now, it was known that NDRG1 expression is
induced by DNA damage in a p53-dependent fashion, and
it is necessary but not suﬃcient for p53-mediated caspase
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Figure 4: DIM treatment eﬀect on alkaline phosphatase activity.
Alkaline phosphatase activity (diﬀerentiation factor of colon cells)
was detected after 4 and 8 hours of treatment. The results are
presented as percentage of control and expressed as means ± SD
of three independent experiments. ∗∗P value <0.001.
activation and apoptosis [8]. The present study shows for the
ﬁrst time that DIM increased NDRG1 expression in a p53
independent pathway followed by induction of apoptosis.
In conclusion, in this study, we provide evidence that
the indole diet-derived DIM induce apoptosis in two human
colon cancer cell lines, well- and poorly diﬀerentiated. How-
ever, induction of apoptosis by DIM is followed by increased
NDRG1 expression only in a poorly diﬀerentiated and p53
mutant cells. On the other hand, DIM induced apoptosis in
well-diﬀerentiated cells in a NDRG1-independent pathway.
Our results may contribute to a better understanding of the4 Journal of Biomedicine and Biotechnology
molecular mechanisms by which DIM exerts its eﬀects in
colon cancer cells and tumors. It is suggested that NDRG1
is not only a diﬀerentiation factor but might impact the
apoptotic process. In all the NDRG1 transfection studies,
apoptotic eﬀects should be taken in account. In fact, NDRG1
is on the list of metastatic-related/cancer suicide genes drug
development in the battle against cancer [33, 34]. Further
studies are needed in order to examine NDRG1 role in
colon cancer genesis. Results from the present research may
contribute to the development of new and eﬃcient strategies
for colon cancer therapy.
Conﬂict of Interests
The authors declare no potential conﬂict of interests with
respect to the authorship and/or publication of this paper.
References
[1] S. K. Kurdistani, P. Arizti, C. L. Reimer, M. M. Sugrue, S. A.
Aaronson, and S. W. Lee, “Inhibition of tumor cell growth by
RTP/rit42 and its responsiveness to p53 and DNA damage,”
Cancer Research, vol. 58, no. 19, pp. 4439–4444, 1998.
[ 2 ]T .P .E l l e n ,Q .K e ,P .Z h a n g ,a n dM .C o s t a ,“ N D R G 1 ,a
growth and cancer related gene: regulation of gene expression
andfunction in normal and disease states,” Carcinogenesis, vol.
29, no. 1, pp. 2–8, 2008.
[3] K. Kokame, H. Kato, and T. Miyata, “Homocysteine-
respondent genes in vascular endothelial cells identiﬁed by
diﬀerential display analysis: GRP78/BiP and novel genes,”
Journal of Biological Chemistry, vol. 271, no. 47, pp. 29659–
29665, 1996.
[4] H. Park, M. A. Adams, P. Lachat, F. Bosman, S. C. Pang,
and C. H. Graham, “Hypoxia induces the expression of a
43-kDa protein (PROXY-1) in normal and malignant cells,”
Biochemical and Biophysical Research Communications, vol.
276, no. 1, pp. 321–328, 2000.
[5] W. Ulrix, J. V. Swinnen, W. Heyns, and G. Verhoeven, “The
diﬀerentiation-related gene 1, Drg1, is markedly upregulated
byandrogensinLNCaPprostaticadenocarcinomacells,”FEBS
Letters, vol. 455, no. 1-2, pp. 23–26, 1999.
[6] D. Zhou, K. Salnikow, and M. Costa, “Cap43, a novel gene
speciﬁcally induced by Ni2+ compounds,” Cancer Research,
vol. 58, no. 10, pp. 2182–2189, 1998.
[7] A. Kitowska and T. Pawełczyk, “N-myc downstream regulated
1 gene and itsplace in the cellular machinery,” Acta Biochimica
Polonica, vol. 57, no. 1, pp. 15–21, 2010.
[8] S. Stein, E. K. Thomas, B. Herzog et al., “NDRG1 is necessary
for p53-dependent apoptosis,” Journal of Biological Chemistry,
vol. 279, no. 47, pp. 48930–48940, 2004.
[9] H. Cangul, “Hypoxia upregulates the expression of the
NDRG1 gene leading to its overexpression in various human
cancers,” BMC Genetics, vol. 5, article 27, 2004.
[10] M. A. Shah, N. Kemeny, A. Hummer et al., “Drg1 expression
in 131 colorectal liver metastases: correlation with clinical
variables and patient outcomes,” Clinical Cancer Research, vol.
11, no. 9, pp. 3296–3302, 2005.
[11] B.Strzelczyk,A.Szulc,R.Rzepkoetal.,“Identiﬁcationofhigh-
risk stage II colorectal tumors by combined analysis of the
NDRG1 gene expression and the depth of tumor invasion,”
Annals of Surgical Oncology, vol. 16, no. 5, pp. 1287–1294,
2009.
[12] E. Angst, D. W. Dawson, D. Stroka et al., “N-myc downstream
regulatedgene-1expressioncorrelateswithreducedpancreatic
cancer growth and increased apoptosis in vitro and in vivo,”
Surgery, vol. 149, no. 5, pp. 614–624, 2011.
[13] X.Yan,M.S.Chua,H.Sun,andS.So,“N-Mycdown-regulated
gene 1 mediates proliferation, invasion, and apoptosis of
hepatocellular carcinoma cells,” Cancer Letters, vol. 262, no. 1,
pp. 133–142, 2008.
[14] O. I. Vivar, C. L. Lin, G. L. Firestone, and L. F. Bjeldanes,
“3,3 -DiindolylmethaneinducesaG1arrestinhumanprostate
cancer cells irrespective of androgen receptor and p53 status,”
Biochemical Pharmacology, vol. 78, no. 5, pp. 469–476, 2009.
[15] X. Ge, S. Yannai, G. Rennert, N. Gruener, and F. A. Fares,
“3,3 -diindolylmethane induces apoptosis in human cancer
cells,” Biochemical and Biophysical Research Communications,
vol. 228, no. 1, pp. 153–158, 1996.
[16] F. A. Fares, X. Ge, S. Yannai, and G. Rennert, “Dietary indole
derivatives induce apoptosis in human breast cancer cells,”
Advances in Experimental Medicine and Biology, vol. 451, pp.
153–157, 1998.
[17] C.Bonnesen,I.M.Eggleston,andJ.D.Hayes,“Dietaryindoles
and isothiocyanates that are generated from cruciferous
vegetables can both stimulate apoptosis and confer protection
against DNA damage in human colon cell lines,” Cancer
Research, vol. 61, no. 16, pp. 6120–6130, 2001.
[ 1 8 ]D .Z .C h e n ,M .Q i ,K .J .A u b o r n ,a n dT .H .C a r t e r ,“ I n d o l e -
3-carbinol and diindolylmethane induce apoptosis of human
cervical cancer cells and in murine HPV16-transgenic preneo-
plastic cervical epithelium,” Journal of Nutrition, vol. 131, no.
12, pp. 3294–3302, 2001.
[19] S. R. Chinni, Y. Li, S. Upadhyay, P. K. Koppolu, and F.
H. Sarkar, “Indole-3-carbinol (I3C) induced cell growth
inhibition,G1cellcyclearrestandapoptosisinprostatecancer
cells,” Oncogene, vol. 20, no. 23, pp. 2927–2936, 2001.
[20] M. Nachshon-Kedmi, S. Yannai, A. Haj, and F. A. Fares,
“Indole-3-carbinol and 3,3 -diindolylmethane induce apop-
tosis in human prostate cancer cells,” Food and Chemical
Toxicology, vol. 41, no. 6, pp. 745–752, 2003.
[21] M. Nachshon-Kedmi, F. A. Fares, and S. Yannai, “Therapeutic
activity of 3,3 -diindolylmethane on prostate cancer in an in
vivo model,” Prostate, vol. 61, no. 2, pp. 153–160, 2004.
[22] T. Mosmann, “Rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity
assays,” Journal of Immunological Methods,v o l .6 5 ,n o .1 - 2 ,p p .
55–63, 1983.
[23] A. R. Goeptar, E. J. Groot, H. Scheerens, J. N. M. Comman-
deur, and N. P. E. Vermeulen, “Cytotoxicity of mitomycin C
and Adriamycin in freshly isolated rat hepatocytes: the role of
cytochrome P450,” Cancer Research, vol. 54, no. 9, pp. 2411–
2418, 1994.
[24] J. H. Moran and R. G. Schnellmann, “A rapid β-NADH-linked
ﬂuorescence assay for lactate dehydrogenase in cellular death,”
Journal of Pharmacological and Toxicological Methods, vol. 36,
no. 1, pp. 41–44, 1996.
[25] P. M. O’Connor, K. Wassermann, M. Sarang, I. Magrath, V.
A. Bohr, and K. W. Kohn, “Relationship between DNA cross-
links, cell cycle, and apoptosis in Burkitt’s lymphoma cell lines
diﬀering in sensitivity to nitrogen mustard,” Cancer Research,
vol. 51, no. 24, pp. 6550–6557, 1991.
[26] B. Almog, O. Fainaru, R. Gamzu et al., “Placental apoptosis in
discordant twins,” Placenta, vol. 23, no. 4, pp. 331–336, 2002.
[27] G. A. Turowski, Z. Rashid, F. Hong, J. A. Madri, and M.
D. Basson, “Glutamine modulates phenotype and stimulatesJournal of Biomedicine and Biotechnology 5
proliferation in human colon cancer cell lines,” Cancer
Research, vol. 54, no. 22, pp. 5974–5980, 1994.
[28] M. Nachshon-Kedmi, S. Yannai, A. Haj, and F. A. Fares,
“Indole-3-carbinol and 3,3 -diindolylmethane induce apop-
tosis in human prostate cancer cells,” Food and Chemical
Toxicology, vol. 41, no. 6, pp. 745–752, 2003.
[29] J. V. Higdon, B. Delage, D. E. Williams, and R. H. Dashwood,
“Cruciferousvegetablesandhumancancerrisk:epidemiologic
evidence and mechanistic basis,” Pharmacological Research,
vol. 55, no. 3, pp. 224–236, 2007.
[30] N. Van Belzen, W. N. M. Dinjens, M. P. G. Diesveld et al., “A
novel gene which is up-regulated during colon epithelial cell
diﬀerentiation and down-regulated in colorectal neoplasms,”
Laboratory Investigation, vol. 77, no. 1, pp. 85–92, 1997.
[31] K. Jiang, Z. Shen, Y. Ye, X. Yang, and S. Wang, “A novel
molecular marker for early detection and evaluating prog-
nosis of gastric cancer: N-myc downstream regulated gene-1
(NDRG1),” Scandinavian Journal of Gastroenterology, vol. 45,
no. 7-8, pp. 898–908, 2010.
[32] T. Ando, H. Ishiguro, M. Kimura et al., “Decreased expression
of NDRG1 is correlated with tumor progression and poor
prognosis in patients with esophageal squamous cell carci-
noma,” Diseases of the Esophagus, vol. 19, no. 6, pp. 454–458,
2006.
[33] M. Iiizumi, W. Liu, S. K. Pai, E. Furuta, and K. Watabe,
“Drug development against metastasis-related genes and their
pathways: a rationale for cancer therapy,” Biochimica et
Biophysica Acta, vol. 1786, no. 2, pp. 87–104, 2008.
[34] L. Teimoori-Toolabi, K. Azadmanesh, A. Amanzadeh, and
S. Zeinali, “Selective suicide gene therapy of colon cancer
exploiting the urokinase plasminogen activator receptor pro-
moter,” BioDrugs, vol. 24, no. 2, pp. 131–146, 2010.